CannaPharmaRX, Inc. (CPMD)
OTCMKTS
· Delayed Price · Currency is USD
0.0034
-0.0001 (-2.86%)
Apr 29, 2026, 10:36 AM EST
CannaPharmaRX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1.36 | 0.82 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | 66.09% | - | - | - | - | Upgrade
|
| Cost of Revenue | 3.75 | 3.76 | 0.07 | 0.03 | - | Upgrade
|
| Gross Profit | -2.39 | -2.93 | -0.07 | -0.03 | - | Upgrade
|
| Selling, General & Admin | 0.96 | 0.7 | 1.28 | 4.6 | 2.25 | Upgrade
|
| Other Operating Expenses | - | - | 0.1 | 0.1 | - | Upgrade
|
| Operating Expenses | 0.96 | 0.7 | 1.51 | 5.18 | 2.62 | Upgrade
|
| Operating Income | -3.35 | -3.63 | -1.58 | -5.21 | -2.62 | Upgrade
|
| Interest Expense | -2.45 | -2.26 | -1.7 | -2.29 | -1.51 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.07 | 0.02 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 1.05 | -3.34 | 0.15 | -0.1 | 3.17 | Upgrade
|
| EBT Excluding Unusual Items | -4.68 | -9.22 | -3.13 | -7.6 | -0.95 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.38 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.52 | - | -0.08 | - | -6.67 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.62 | Upgrade
|
| Other Unusual Items | -1.93 | -0.69 | 6.89 | -0.93 | -1.45 | Upgrade
|
| Pretax Income | -11.13 | -9.91 | 3.69 | -8.53 | -8.83 | Upgrade
|
| Net Income | -11.13 | -9.91 | 3.69 | -8.53 | -8.83 | Upgrade
|
| Net Income to Common | -11.13 | -9.91 | 3.69 | -8.53 | -8.83 | Upgrade
|
| Shares Outstanding (Basic) | 663 | 625 | 309 | 211 | 75 | Upgrade
|
| Shares Outstanding (Diluted) | 663 | 625 | 309 | 211 | 75 | Upgrade
|
| Shares Change (YoY) | 5.95% | 102.40% | 46.38% | 182.57% | 83.50% | Upgrade
|
| EPS (Basic) | -0.02 | -0.02 | 0.01 | -0.04 | -0.12 | Upgrade
|
| EPS (Diluted) | -0.02 | -0.02 | 0.01 | -0.04 | -0.12 | Upgrade
|
| Free Cash Flow | -0.79 | -1.7 | -2.36 | -1.56 | -2.42 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.03 | Upgrade
|
| Gross Margin | -175.34% | - | - | - | - | Upgrade
|
| Operating Margin | -245.77% | -442.72% | - | - | - | Upgrade
|
| Profit Margin | -817.19% | -1207.82% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -58.34% | -206.94% | - | - | - | Upgrade
|
| EBITDA | - | -3.51 | -1.45 | -4.91 | -2.61 | Upgrade
|
| D&A For EBITDA | - | 0.12 | 0.13 | 0.29 | 0 | Upgrade
|
| EBIT | -3.35 | -3.63 | -1.58 | -5.21 | -2.62 | Upgrade
|
| EBIT Margin | -245.77% | - | - | - | - | Upgrade
|
| Advertising Expenses | - | - | 0.03 | 0.3 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.